The risk or severity of adverse effects can be increased when Midazolam is combined with Paliperidone. The serum concentration of Doxorubicin can be increased when it is combined with Midazolam. The risk or severity of adverse effects can be increased when Eszopiclone is combined with Midazolam. The risk or severity of adverse effects can be increased when Midazolam is combined with Olopatadine. The serum concentration of Midazolam can be decreased when it is combined with Deferasirox. The metabolism of Midazolam can be increased when combined with Rifampicin. The risk or severity of adverse effects can be increased when Midazolam is combined with Sertindole. The risk or severity of adverse effects can be increased when Midazolam is combined with Dezocine. The risk or severity of adverse effects can be increased when Midazolam is combined with Ethylmorphine. The serum concentration of Ledipasvir can be decreased when it is combined with Midazolam. The risk or severity of adverse effects can be increased when Midazolam is combined with Etorphine. The risk or severity of adverse effects can be increased when Hydromorphone is combined with Midazolam. The serum concentration of Midazolam can be increased when it is combined with Ramipril. The risk or severity of adverse effects can be increased when Alprazolam is combined with Midazolam. The serum concentration of Midazolam can be increased when it is combined with Nitroaspirin. The serum concentration of Midazolam can be increased when it is combined with GM6001. The risk or severity of adverse effects can be increased when Midazolam is combined with Alfentanil. The risk or severity of adverse effects can be increased when Midazolam is combined with Zimelidine. The serum concentration of Midazolam can be increased when it is combined with Tipranavir. The serum concentration of Midazolam can be decreased when it is combined with St. John's Wort. The risk or severity of adverse effects can be increased when Midazolam is combined with Clobazam. The risk or severity of adverse effects can be increased when Midazolam is combined with Levocabastine. The risk or severity of adverse effects can be increased when Midazolam is combined with Zotepine. The risk or severity of adverse effects can be increased when Midazolam is combined with Flurazepam. The serum concentration of Midazolam can be increased when it is combined with Epigallocatechin Gallate. The serum concentration of Midazolam can be increased when it is combined with Temocapril. The metabolism of Midazolam can be decreased when combined with Sildenafil. The metabolism of Midazolam can be decreased when combined with Ziprasidone. Midazolam may increase the central nervous system depressant (CNS depressant) activities of Ethanol. The risk or severity of adverse effects can be increased when Midazolam is combined with Dexmedetomidine. The risk or severity of adverse effects can be increased when Midazolam is combined with Methaqualone. The serum concentration of Midazolam can be increased when it is combined with Palbociclib. The risk or severity of adverse effects can be increased when Midazolam is combined with Proparacaine. The risk or severity of adverse effects can be increased when Midazolam is combined with Acepromazine. The risk or severity of adverse effects can be increased when Secobarbital is combined with Midazolam. The risk or severity of adverse effects can be increased when Midazolam is combined with Diphenhydramine. The serum concentration of Midazolam can be increased when it is combined with Fosaprepitant. The serum concentration of Midazolam can be increased when it is combined with Teduglutide. The risk or severity of adverse effects can be increased when Midazolam is combined with Gepirone. The risk or severity of adverse effects can be increased when Midazolam is combined with Agomelatine. The risk or severity of adverse effects can be increased when Midazolam is combined with Nitrazepam. The serum concentration of Mevastatin can be increased when it is combined with Midazolam. The risk or severity of adverse effects can be increased when Midazolam is combined with Opium. The serum concentration of Midazolam can be increased when it is combined with Chymostatin. The risk or severity of adverse effects can be increased when Midazolam is combined with Milnacipran. Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Midazolam. The serum concentration of Ubidecarenone can be increased when it is combined with Midazolam. The serum concentration of Midazolam can be increased when it is combined with Ximelagatran. The risk or severity of adverse effects can be increased when Midazolam is combined with Ropivacaine. The risk or severity of adverse effects can be increased when Midazolam is combined with Tiagabine. The metabolism of Midazolam can be decreased when combined with Imatinib. The risk or severity of adverse effects can be increased when Midazolam is combined with Etifoxine. The risk or severity of adverse effects can be increased when Midazolam is combined with Indalpine. The serum concentration of Midazolam can be increased when it is combined with Ivacaftor. The risk or severity of adverse effects can be increased when Midazolam is combined with Benzocaine. The risk or severity of adverse effects can be increased when Chlordiazepoxide is combined with Midazolam. The risk or severity of adverse effects can be increased when Midazolam is combined with Ramelteon. The serum concentration of Midazolam can be increased when it is combined with 3,4-Dichloroisocoumarin. The risk or severity of adverse effects can be increased when Oxycodone is combined with Midazolam. The risk or severity of adverse effects can be increased when Midazolam is combined with Zopiclone. The metabolism of Midazolam can be increased when combined with Pentobarbital. The risk or severity of adverse effects can be increased when Bromocriptine is combined with Midazolam. The risk or severity of adverse effects can be increased when Midazolam is combined with Tiapride. The metabolism of Midazolam can be decreased when combined with Nilotinib. The risk or severity of adverse effects can be increased when Metergoline is combined with Midazolam. The risk or severity of adverse effects can be increased when Midazolam is combined with Tasimelteon. The serum concentration of Midazolam can be decreased when it is combined with Bosentan. The risk or severity of adverse effects can be increased when Midazolam is combined with Butamben. The risk or severity of adverse effects can be increased when Midazolam is combined with Tizanidine. The serum concentration of Midazolam can be increased when it is combined with Darunavir. The risk or severity of adverse effects can be increased when Midazolam is combined with Tetrahydropalmatine. The serum concentration of Sofosbuvir can be decreased when it is combined with Midazolam. The risk or severity of adverse effects can be increased when Midazolam is combined with Dexbrompheniramine. The metabolism of Midazolam can be increased when combined with Nevirapine. The serum concentration of Colchicine can be increased when it is combined with Midazolam. The serum concentration of Midazolam can be increased when it is combined with Gabexate. The metabolism of Midazolam can be decreased when combined with Dronedarone. The risk or severity of adverse effects can be increased when Midazolam is combined with Meclizine. The risk or severity of adverse effects can be increased when Midazolam is combined with Osanetant. The serum concentration of Midazolam can be increased when it is combined with Argatroban. The metabolism of Midazolam can be decreased when combined with Thiotepa. The risk or severity of adverse effects can be increased when Pethidine is combined with Midazolam. The risk or severity of adverse effects can be increased when Midazolam is combined with Lofentanil. The serum concentration of Midazolam can be decreased when it is combined with Tocilizumab. The risk or severity of adverse effects can be increased when Midazolam is combined with Pomalidomide. The serum concentration of Midazolam can be increased when it is combined with Elafin. The risk or severity of adverse effects can be increased when Midazolam is combined with Efavirenz. The risk or severity of adverse effects can be increased when Midazolam is combined with Desipramine. The serum concentration of Afatinib can be decreased when it is combined with Midazolam. The serum concentration of Edoxaban can be increased when it is combined with Midazolam. The serum concentration of Fosphenytoin can be increased when it is combined with Midazolam. The serum concentration of Midazolam can be increased when it is combined with Asunaprevir. The serum concentration of Linagliptin can be decreased when it is combined with Midazolam. The serum concentration of Midazolam can be increased when it is combined with Rivaroxaban. The risk or severity of adverse effects can be increased when Midazolam is combined with Quetiapine. The serum concentration of Midazolam can be increased when it is combined with Moexipril. The risk or severity of adverse effects can be increased when Midazolam is combined with Butalbital. The risk or severity of adverse effects can be increased when Midazolam is combined with Etidocaine. The serum concentration of Midazolam can be increased when it is combined with Boceprevir. The risk or severity of adverse effects can be increased when Midazolam is combined with Flibanserin. The risk or severity of adverse effects can be increased when Midazolam is combined with Tolcapone. The serum concentration of Midazolam can be increased when it is combined with Ecabet. The risk or severity of adverse effects can be increased when Midazolam is combined with Chlormezanone. The metabolism of Midazolam can be decreased when combined with Sertraline. The risk or severity of adverse effects can be increased when Midazolam is combined with Flunarizine. The risk or severity of adverse effects can be increased when Meprobamate is combined with Midazolam. The metabolism of Midazolam can be increased when combined with Rifapentine. The metabolism of Midazolam can be increased when combined with Carbamazepine. The risk or severity of adverse effects can be increased when Midazolam is combined with Ethchlorvynol. The risk or severity of adverse effects can be increased when Midazolam is combined with Levomilnacipran. The risk or severity of adverse effects can be increased when Midazolam is combined with Fentanyl. The risk or severity of adverse effects can be increased when Midazolam is combined with Felbamate. The risk or severity of adverse effects can be increased when Midazolam is combined with Ethotoin. The risk or severity of adverse effects can be increased when Midazolam is combined with Levocetirizine. The metabolism of Midazolam can be decreased when combined with Ticlopidine. The risk or severity of adverse effects can be increased when Methohexital is combined with Midazolam. Midazolam may increase the sedative activities of Metyrosine. The risk or severity of adverse effects can be increased when Midazolam is combined with Perazine. The serum concentration of Midazolam can be increased when it is combined with N-(3-Propylcarbamoyloxirane-2-Carbonyl)-Isoleucyl-Proline. The serum concentration of Midazolam can be increased when it is combined with Trandolapril. The risk or severity of adverse effects can be increased when Midazolam is combined with Topiramate. Midazolam may increase the sedative activities of Pramipexole. The risk or severity of adverse effects can be increased when Midazolam is combined with Desflurane. The serum concentration of Midazolam can be increased when it is combined with Benzamidine. The risk or severity of adverse effects can be increased when Midazolam is combined with Isoflurane. The risk or severity of adverse effects can be increased when Midazolam is combined with Benperidol. Midazolam may increase the central nervous system depressant (CNS depressant) activities of Methotrimeprazine. The serum concentration of Midazolam can be increased when it is combined with Alpha-1-proteinase inhibitor. The metabolism of Midazolam can be decreased when combined with Lovastatin. The serum concentration of Midazolam can be increased when it is combined with Spirapril.